17.2 Pediatric Induction, Maintenance, Fluids & Emergence Agitation

Key Takeaways

  • Inhalational induction with Sevoflurane (titrated up to 8% in 70/30 N₂O/O₂ or 100% O₂) is the gold standard for needle-phobic, cooperative children without aspiration risks; IV induction with Propofol requires a higher pediatric dose (2.5 to 3.5 mg/kg) due to an expanded central distribution volume and rapid hepatic clearance.
  • Endotracheal tube (ETT) internal diameter (ID) sizing is calculated using standard formulas: Cole uncuffed ID = (Age / 4) + 4; Khine/Motoyama cuffed ID = (Age / 4) + 3.5; depth of insertion at the lip is estimated by (Age / 2) + 12 cm or 3 × ETT ID.
  • A mandatory ETT leak test must demonstrate an audible air leak at 15 to 25 cmH₂O; a leak at <10-15 cmH₂O indicates inadequate seal and aspiration risk, whereas absence of a leak at >25 cmH₂O risks ischemic mucosal injury over the cricoid ring, post-extubation croup, and subglottic stenosis.
  • Intraoperative fluid management uses balanced isotonic crystalloids (Lactated Ringer's or Plasma-Lyte) guided by the 4-2-1 rule plus NPO deficit replacement (50% in hour 1, 25% in hour 2, 25% in hour 3); routine dextrose is avoided except in neonates, premature infants, SGA infants, or prolonged cases (maintaining blood glucose 60 to 150 mg/dL).
  • Maximum Allowable Blood Loss (MABL) is determined from age-adjusted Estimated Blood Volume (Preterm: 90-100 mL/kg, Term neonate: 80-90 mL/kg, Infant: 75-80 mL/kg, Child: 70-75 mL/kg) via MABL = EBV × [(Hct_initial - Hct_target) / Hct_initial]; Emergence Agitation (EA) is prevented with Propofol 1 mg/kg at emergence, Dexmedetomidine 0.3-0.5 mcg/kg IV, and regional/caudal blockade.
Last updated: August 2026

17.2 Pediatric Induction, Maintenance, Fluids & Emergence Agitation

Administering anesthesia to pediatric patients demands flawless execution of airway management, meticulous fluid balance calculations, and aggressive strategies to mitigate post-anesthesia emergence delirium. Mastery of age-specific tube formulas, hemodynamic monitoring, and fluid homeostasis is foundational to safe pediatric practice.


1. Pediatric Induction Techniques

Induction strategies are tailored to the child's developmental age, fasting status, anxiety level, and pre-existing medical conditions.

+---------------------------------------------------------------------------------------------------------+
|                                PEDIATRIC INDUCTION STRATEGIES & DOSING                                  |
+---------------------+-------------------------------+---------------------------------------------------+
| Technique           | Drug Regimen                  | Clinical Indications & Critical Nuances           |
+---------------------+-------------------------------+---------------------------------------------------+
| **Inhalational**    | • Sevoflurane (up to 8%)      | • Gold standard for needle-phobic, cooperative    |
| **Induction**       | • 70% N₂O / 30% O₂ or 100% O₂ |   children without full stomach / reflux risks    |
|                     | • High fresh gas flow (6-8 LPM| • Maintain quiet OR; do not stimulate in Stage II |
+---------------------+-------------------------------+---------------------------------------------------+
| **Intravenous**     | • Propofol **2.5 - 3.5 mg/kg**| • Rapid, reliable onset with pre-existing IV      |
| **Induction**       | • Fentanyl **1 - 2 mcg/kg**   | • Requires higher dose in infants due to expanded |
|                     | • Lidocaine 0.5 - 1 mg/kg     |   central compartment and rapid glucuronidation   |
+---------------------+-------------------------------+---------------------------------------------------+
| **Intramuscular**   | • Ketamine **3 - 5 mg/kg** IM | • Uncooperative, combative, or autistic child     |
| **"Dart" Induction**| • Glycopyrrolate 0.01 mg/kg IM|   without IV access; onset 3 - 5 minutes          |
|                     | • Midazolam 0.1 mg/kg IM      | • Glycopyrrolate prevents severe hypersalivation  |
+---------------------+-------------------------------+---------------------------------------------------+
| **Rapid Sequence**  | • Propofol 3 mg/kg +          | • Full stomach, trauma, acute abdomen, bowel      |
| **Induction (RSI)** |   Succinylcholine 2 mg/kg IV  |   obstruction; cricoid pressure controversial;    |
|                     |   (or Rocuronium 1.2 mg/kg IV)|   pre-treat with Atropine 0.02 mg/kg IV           |
+---------------------+-------------------------------+---------------------------------------------------+

Inhalational Induction Nuances & Stage II Management

  • Stepped vs. High-Dose Single-Breath Technique: Inhalational induction can be performed by stepping up Sevoflurane by $1% - 2%$ every few breaths or priming the circuit with $8%$ Sevoflurane in $70% \text{ N}_2\text{O} / 30% \text{ O}_2$ for a rapid single-breath induction. Sevoflurane is the volatile agent of choice because it is non-pungent, non-irritating to the tracheobronchial tree, and produces rapid loss of consciousness without airway secretions.
  • Navigating Stage II Anesthesia: As the child transitions from consciousness to surgical anesthesia, they pass through Stage II (the excitement stage), characterized by irregular breathing, breath-holding, conjugate/dysconjugate roving eye movements, hyperreflexia, and heightened laryngeal sensitivity. No airway manipulation, IV starts, or patient repositioning should occur during Stage II, as tactile or painful stimulation during this light plane readily triggers catastrophic laryngospasm or severe bronchospasm.

2. Endotracheal Tube Sizing, Depth & Leak Testing

Modern pediatric anesthesia utilizes micro-cuffed endotracheal tubes (with ultra-thin polyurethane cuffs) down to full-term neonates. Cuffed tubes provide a reliable seal at low mucosal pressures ($<20 \text{ cmH}_2\text{O}$), reduce tube exchange rates, ensure accurate end-tidal gas and spirometry monitoring, and decrease theater pollution.

+---------------------------------------------------------------------------------------------------------+
|                                 ENDOTRACHEAL TUBE SIZING FORMULAS                                       |
+-------------------------+-----------------------------------+-------------------------------------------+
| Tube Type               | Calculation Formula               | Example for 4-Year-Old Child              |
+-------------------------+-----------------------------------+-------------------------------------------+
| **Uncuffed ETT ID**     | **$\text{ID} = \frac{\text{Age}}{4} + 4$**   | $\frac{4}{4} + 4 = \mathbf{5.0\text{ mm ID}}$             |
| (Cole Formula)          |                                   |                                           |
+-------------------------+-----------------------------------+-------------------------------------------+
| **Cuffed ETT ID**       | **$\text{ID} = \frac{\text{Age}}{4} + 3.5$** | $\frac{4}{4} + 3.5 = \mathbf{4.5\text{ mm ID}}$           |
| (Khine / Motoyama)      |                                   |                                           |
+-------------------------+-----------------------------------+-------------------------------------------+
| **Modified Duracher**   | **$\text{ID} = \frac{\text{Age}}{4} + 3.0$** | $\frac{4}{4} + 3.0 = \mathbf{4.0\text{ mm ID}}$ (infants) |
| (Infants <2 years)      |                                   |                                           |
+-------------------------+-----------------------------------+-------------------------------------------+
| **Depth of Insertion**  | **$\text{Depth (cm)} = \frac{\text{Age}}{2} + 12$** | $\frac{4}{2} + 12 = \mathbf{14\text{ cm}}$ at the lip     |
| (Alveolar Ridge / Lip)  | **$\text{Depth (cm)} = 3 \times \text{ETT ID}$**   | $3 \times 4.5 = \mathbf{13.5\text{ cm}}$ at the lip       |
+-------------------------+-----------------------------------+-------------------------------------------+
+---------------------------------------------------------------------------------------------------------+
|                                  AGE-SPECIFIC TUBE SELECTION GUIDELINE                                  |
+-----------------------------+-----------------------------+----------------------+----------------------+
| Age Group                   | Uncuffed ETT (mm ID)        | Cuffed ETT (mm ID)   | Insertion Depth (cm) |
+-----------------------------+-----------------------------+----------------------+----------------------+
| **Premature (<1000 g)**     | 2.5                         | Not recommended      | 6 - 7 cm             |
| **Premature (1000 - 2500 g)**| 3.0                        | 2.5                  | 7 - 8 cm             |
| **Full-Term Neonate**       | 3.0 - 3.5                   | 3.0                  | 9 - 10 cm            |
| **Infant (1 - 12 months)**  | 3.5 - 4.0                   | 3.0 - 3.5            | 10 - 12 cm           |
| **Child 1 - 2 years**       | 4.0 - 4.5                   | 3.5 - 4.0            | 12 - 13 cm           |
| **Child >2 years**          | $(\text{Age}/4) + 4$        | $(\text{Age}/4) + 3.5$| $(\text{Age}/2) + 12$|
+-----------------------------+-----------------------------+----------------------+----------------------+

The Mandatory Endotracheal Tube Leak Test

Following intubation, an objective cuff leak test must be performed to ensure mucosal capillary perfusion is preserved:

  1. Connect breathing circuit, close the Adjustable Pressure Limiting (APL) valve, and place a stethoscope over the anterior laryngeal/tracheal cartilage.
  2. Manually inflate the circuit reservoir bag until an audible air escape (leak) is auscultated at the mouth.
  3. Ideal Leak Threshold: An audible leak should occur at $15 - 25 \text{ cmH}_2\text{O}$ of peak airway pressure.
    • Leak $<10 - 15 \text{ cmH}_2\text{O}$: Inadequate seal. Results in hypoventilation, loss of positive end-expiratory pressure (PEEP), inaccurate spirometry, and aspiration of gastric contents. Inflate cuff gently with minimal air ($<20 \text{ cmH}_2\text{O}$ cuff pressure) or replace with $0.5 \text{ mm}$ larger ETT.
    • No Leak at $>25 \text{ cmH}_2\text{O}$: Tube is too tight. Capillary perfusion pressure of the subglottic cricoid mucosa is approximately $25 - 30 \text{ mmHg}$ ($30 - 35 \text{ cmH}_2\text{O}$). Prolonged pressure exceeding this threshold causes circumferential mucosal ischemia, mucosal ulceration, post-extubation croup (stridor), and permanent subglottic cicatricial stenosis. Downsize the ETT by $0.5 \text{ mm}$ ID immediately.

3. Intraoperative Fluid Management & Glucose Regulation

Pediatric fluid management has evolved dramatically over the past two decades, transitioning away from routine hypotonic dextrose solutions toward balanced isotonic crystalloids.

The Holliday-Segar 4-2-1 Maintenance Rule

Maintenance hourly fluid requirements are calculated based on weight brackets:

+---------------------------------------------------------------------------------------------------------+
|                                 THE 4-2-1 HOURLY MAINTENANCE FLUID RULE                                 |
+------------------------------------+--------------------------------------------------------------------+
| Weight Category                    | Hourly Fluid Rate Calculation                                      |
+------------------------------------+--------------------------------------------------------------------+
| **First 10 kg (1 - 10 kg)**        | • **4 mL/kg/hr**                                                   |
+------------------------------------+--------------------------------------------------------------------+
| **Second 10 kg (11 - 20 kg)**      | • **40 mL/hr + 2 mL/kg/hr** for every kg between 11 and 20 kg      |
+------------------------------------+--------------------------------------------------------------------+
| **Each kg Above 20 kg (>20 kg)**   | • **60 mL/hr + 1 mL/kg/hr** for every kg above 20 kg               |
|                                    | • *Quick shortcut for >20 kg:* **Weight in kg + 40 = mL/hr**       |
+------------------------------------+--------------------------------------------------------------------+

Calculation of NPO Deficit & Intraoperative Replacement

Total NPO Deficit=Hourly Maintenance Rate×Hours Fasting (NPO)\text{Total NPO Deficit} = \text{Hourly Maintenance Rate} \times \text{Hours Fasting (NPO)}

  • Intraoperative Replacement Schedule:
    • Hour 1 of Surgery: $50%$ of NPO Deficit $+$ Hourly Maintenance $+$ Surgical Third-Space Loss
    • Hour 2 of Surgery: $25%$ of NPO Deficit $+$ Hourly Maintenance $+$ Surgical Third-Space Loss
    • Hour 3 of Surgery: $25%$ of NPO Deficit $+$ Hourly Maintenance $+$ Surgical Third-Space Loss
  • Surgical Tissue Trauma / Third-Space Losses:
    • Mild trauma (e.g., hernia repair, strabismus): $1 - 2 \text{ mL/kg/hr}$
    • Moderate trauma (e.g., open appendectomy, tonsillectomy): $3 - 5 \text{ mL/kg/hr}$
    • Severe trauma (e.g., major bowel resection, thoracotomy): $6 - 10 \text{ mL/kg/hr}$

Fluid Selection: Isotonic vs. Hypotonic & Dextrose Indications

  • Avoid Hypotonic Crystalloids: Historical administration of hypotonic fluids (e.g., $D_5 0.2% \text{ NaCl}$) combined with stress-induced non-osmotic Anti-Diuretic Hormone (ADH) secretion led to disastrous hospital-acquired acute hyponatremic encephalopathy, cerebral edema, herniation, and death. Standard perioperative maintenance should always utilize balanced isotonic crystalloids (Lactated Ringer's, Plasma-Lyte, Normosol-R, or $0.9%$ Normal Saline).
  • Indications for Dextrose ($D_5W$ in Balanced Isotonic Solution):
    • Neonates and premature infants ($<1$ month of age) with low hepatic glycogen stores and immature gluconeogenesis.
    • Small for Gestational Age (SGA) or low birth weight infants.
    • Children receiving preoperative total parenteral nutrition (TPN) (infusion must not be stopped abruptly; taper or match intraop dextrose).
    • Patients with known mitochondrial or glycogen storage diseases.
    • Target Blood Glucose: $60 - 150 \text{ mg/dL}$. Avoid hyperglycemia ($>180 - 200 \text{ mg/dL}$), as it triggers hyperosmotic diuresis, electrolyte wasting, and exacerbates lactic acidosis and neuronal apoptosis during periods of cerebral ischemia.

4. Blood Volume & Maximum Allowable Blood Loss (MABL)

Accurate assessment of intraoperative blood loss requires knowledge of age-specific Estimated Blood Volume (EBV) and strict calculation of the transfusion threshold.

+---------------------------------------------------------------------------------------------------------+
|                                ESTIMATED BLOOD VOLUME (EBV) BY AGE GROUP                                |
+------------------------------------+--------------------------------------------------------------------+
| Age Group                          | Estimated Blood Volume (EBV)                                       |
+------------------------------------+--------------------------------------------------------------------+
| **Premature Neonate**              | **90 - 100 mL/kg**                                                 |
| **Full-Term Neonate (<30 days)**   | **80 - 90 mL/kg**                                                  |
| **Infant (1 - 12 months)**         | **75 - 80 mL/kg**                                                  |
| **Child (1 - 12 years)**           | **70 - 75 mL/kg**                                                  |
| **Adult Male / Female**            | **75 mL/kg (Male) / 65 mL/kg (Female)**                            |
+------------------------------------+--------------------------------------------------------------------+

MABL Mathematical Formula

MABL=EBV×(HctstartingHcttargetHctstarting)\text{MABL} = \text{EBV} \times \left( \frac{\text{Hct}_{\text{starting}} - \text{Hct}_{\text{target}}}{\text{Hct}_{\text{starting}}} \right)

Total Blood Volume=Weight (kg)×EBV (mL/kg)\text{Total Blood Volume} = \text{Weight (kg)} \times \text{EBV (mL/kg)}

Step-by-Step Clinical Calculation Example

  • Clinical Scenario: An 8-month-old infant weighing $8 \text{ kg}$ presents for craniofacial surgery. Preoperative hematocrit is $39%$, and the acceptable target hematocrit is $28%$.
  • Step 1: Calculate Total Blood Volume: TBV=8 kg×80 mL/kg=640 mL\text{TBV} = 8 \text{ kg} \times 80 \text{ mL/kg} = 640 \text{ mL}
  • Step 2: Calculate MABL: MABL=640 mL×(392839)=640×(1139)=640×0.282=180.5 mL\text{MABL} = 640 \text{ mL} \times \left( \frac{39 - 28}{39} \right) = 640 \times \left( \frac{11}{39} \right) = 640 \times 0.282 = \mathbf{180.5\text{ mL}}
  • Interpretation: The provider can replace blood loss up to $180 \text{ mL}$ with isotonic crystalloid ($3:1$ ratio) or $5%$ albumin ($1:1$ ratio). Blood loss beyond $180 \text{ mL}$ requires Packed Red Blood Cell (PRBC) transfusion.
  • PRBC Transfusion Volume Formula: Transfusion Volume (mL)=Weight (kg)×(Desired HctActual Hct)×EBVHct of PRBCs (approx 60%)\text{Transfusion Volume (mL)} = \frac{\text{Weight (kg)} \times (\text{Desired Hct} - \text{Actual Hct}) \times \text{EBV}}{\text{Hct of PRBCs (approx 60\%)}} Or clinical rule of thumb: $10 - 15 \text{ mL/kg}$ PRBCs will raise hemoglobin by $2 - 3 \text{ g/dL}$ (Hct by $6 - 9%$).

5. Emergence Agitation (EA) & Delirium in Pediatrics

Emergence Agitation (EA) is a well-recognized clinical syndrome occurring in up to $30% - 50%$ of preschool-aged children undergoing general anesthesia with modern, low-solubility volatile anesthetics.

+---------------------------------------------------------------------------------------------------------+
|                               EMERGENCE AGITATION (EA) CLINICAL PROFILE                                 |
+---------------------+-----------------------------------------------------------------------------------+
| Characteristic      | Clinical Presentation & Features                                                  |
+---------------------+-----------------------------------------------------------------------------------+
| **Definition**      | • State of acute mental distress, non-purposeful thrashing, inconsolable crying,  |
|                     |   combative motor behavior, and lack of eye contact during early recovery (PACU). |
+---------------------+-----------------------------------------------------------------------------------+
| **Peak Age Group**  | • **Toddlers & Preschool children (2 - 5 years of age)**                          |
+---------------------+-----------------------------------------------------------------------------------+
| **Primary Triggers**| • Rapid emergence from insoluble volatile agents (**Sevoflurane**, **Desflurane**) |
|                     | • High baseline child/parent anxiety; preschool developmental stage               |
|                     | • Surgical procedures involving head/neck (ENT, tonsillectomy, strabismus)        |
+---------------------+-----------------------------------------------------------------------------------+
| **Differential Dx** | • **Hypoxemia, Hypercapnia, Acidosis (Must rule out immediately!)**              |
|                     | • Acute surgical pain, bladder distension, airway obstruction, tight casts        |
+---------------------+-----------------------------------------------------------------------------------+
                       [PREVENTATIVE PHARMACOTHERAPY FOR EA]

               [Multi-Targeted Prophylaxis Algorithm]
               /                |                  \
              /                 |                   \
    **Propofol Bolus**   **Alpha-2 Agonists**   **Regional Blocks**
    • 1.0 mg/kg IV       • Dexmedetomidine       • Caudal Epidural
      at end of surgery    0.3 - 0.5 mcg/kg IV     (0.125-0.2% Bupiv)
    • Smooths transition   or 1 - 2 mcg/kg IN    • Peripheral Blocks
      from volatile      • Clonidine 2 mcg/kg    • Complete pain relief

Evidence-Based Prevention and Management Strategies

  1. Propofol Bolus at Emergence: Administering Propofol $1.0 \text{ mg/kg}$ IV at the conclusion of surgery (as volatile anesthetic is discontinued) significantly reduces the incidence of emergence agitation without prolonging PACU discharge time.
  2. Alpha-2 Receptor Agonists: Dexmedetomidine ($0.3 - 0.5 \text{ mcg/kg}$ IV intraoperatively or $1.0 - 2.0 \text{ mcg/kg}$ intranasally preop) provides dose-dependent reduction in EA, decreases opioid consumption, and provides non-respiratory-depressant sedation.
  3. Regional Anesthesia & Analgesia: Caudal epidural analgesia ($1.0 \text{ mL/kg}$ of $0.125% - 0.2%$ Ropivacaine or Bupivacaine) or peripheral nerve blocks eliminate surgical nociception, the primary trigger for post-anesthetic agitation.
  4. Non-Pharmacologic Measures: Maintain a quiet, dimly lit PACU environment; facilitate early parental presence at the bedside as soon as the patient establishes patent airway reflexes.
Loading diagram...
Pediatric Fluid, MABL & Airway Management Algorithm
Test Your Knowledge

A healthy 4-year-old child weighing 16 kg is scheduled for an elective tonsillectomy. Which endotracheal tube size and initial insertion depth at the lip represent the most appropriate clinical selection?

A
B
C
D
Test Your Knowledge

Following intubation of a 3-year-old child with a 4.5 mm ID uncuffed endotracheal tube, the CRNA performs an airway leak test. Peak airway pressure is increased to 35 cmH₂O, and no audible air leak is detected around the tube. What is the most appropriate next action?

A
B
C
D
Test Your Knowledge

A 6-month-old infant weighing 8 kg with a starting hematocrit of 40% undergoes a major craniofacial reconstruction. The surgical and anesthesia team agree that the lowest acceptable target hematocrit is 30%. Using an Estimated Blood Volume of 80 mL/kg, what is the Maximum Allowable Blood Loss (MABL)?

A
B
C
D
Test Your Knowledge

A 3-year-old child emerges from a 45-minute bilateral myringotomy and adenoidectomy under Sevoflurane general anesthesia. In the PACU, the child is thrashing violently, inconsolably screaming, and failing to recognize their parents. Vital signs show SpO₂ 99% on room air and heart rate 125 bpm. What is the most effective pharmacologic intervention to prevent or treat this condition at the end of surgery?

A
B
C
D